Genetic Knowledge is Power
The Expedio™ Hereditary Cancer Testing Service assesses whether or not you are at an increased risk of developing cancer due to inherited changes in your genes. Our test provides your physician with specific information about your genes that can provide great insight into healthcare decisions, such as enhanced screenings, treatments and preventative measures, that may greatly affect your future health and quality of life.*
Sample collection is easy and painless. Simply rub the inside of your cheek
with the sterile swab included in the collection kit and mail the swabs
to Kailos Genetics in the provided envelope. Results are released
to you and your physician within two weeks of sample receipt.
Each genetic variation screened has scientific evidence supporting an increased risk associated with breast, endocrine, gastrointestinal, genitourinary, gynecologic, hematologic, nervous system, soft tissue, bone, and skin cancers.
Gain a Better Understanding of Your Hereditary Risk
*The Expedio™ test is only available to those 18 years of age and older.
*Not available in the states of New York and Maryland.
Not necessarily. It simply means that you have an increased risk of developing a certain cancer when compared to the general population’s risk level. It may mean that your physician chooses an alternate monitoring regimen that makes more sense for your personal risk level. [example - BRCA variant and mammogram age]
You inherited your genetic variation from one of your parents, so either your mother or father have the variation and are at increased risk. Any full siblings or biological children you have will have a 50% chance of inheriting the change as well.
Yes, if you have one of the variations for which we test, the type of cancer your particular variation puts you at an increased risk of developing is listed in the final report we return to you. Each variation we test for is associated with an increased risk in the development of at least one type of cancer. Some genetic variations are associated with an increased risk in the development of more than one cancer type. For example, specific variations in the BRCA2 gene are associated with an increased risk of developing breast, ovarian, pancreatic and prostate cancers.
While your job and health insurance are federally protected against discrimination due to your genetic makeup (GINA), there currently are no such protections for life and long term care insurances. Your results could have ramifications in other areas of your life and the decision to have the testing should be made after careful consideration.